Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The investigational drug showed promise as a component of a “shock and kill” HIV cure approach in a mouse study.
Researchers have been searching for agents that can wake HIV from its resting state in an effort to flush out the viral reservoir.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
CRISPR gene editing eliminates HIV in mice
A new HIV vaccine prompts powerful antibody response in animals.
Research in human cells and mice found the antiretroviral suppressed harmful chronic inflammation linked to age-related disorders.
Researchers have devised a means of injecting an antiretroviral under the skin that hardens into a dissolvable and removable implant.
Researchers have found a way of stabilizing a shape-shifting viral protein so as to promote a greater antibody response.
NIH researchers have prompted animals to develop broadly neutralizing antibodies against the virus; an early human trial is in the works.
The researchers studied a new compound that blocked a key viral protein that prompts infected cells to produce more virus.
For the first time, scientists have used the powerful, cutting-edge CRISPR/Cas9 gene-editing method to snip HIV out of infected mice.
The feat marks an important milestone in the mammoth effort to find a cure for HIV.
Researchers significantly reduced HIV levels in mice with a genetic therapy that prompts immune cells to better fight the virus.
Researchers significantly reduced HIV levels in mice with a genetic therapy that induces immune cells to better fight the virus.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.